UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023668
Receipt number R000027262
Scientific Title The verification study for safety evaluation of test food overdose in human: an open-label trial
Date of disclosure of the study information 2017/06/19
Last modified on 2017/02/01 08:42:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The verification study for safety evaluation of test food overdose in human: an open-label trial

Acronym

The verification study for safety evaluation of test food overdose in human

Scientific Title

The verification study for safety evaluation of test food overdose in human: an open-label trial

Scientific Title:Acronym

The verification study for safety evaluation of test food overdose in human

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the safety of overdose the test food

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1. Body measuring
2. Physical examination
3. Internal medicine examination
4. Blood test
5. Urinalysis
6. Subjective symptom
*1 Perform examinations and tests at 0 week and at 2 and 4 weeks after the ingestion and at follow-up period 2 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Duration: 4 weeks
Follow-up duration: 2 weeks
Test material: "Garlic egg yolk 229-55 ninnikugogo"
Dose: Take five capsules, three times a day
Administration: Take five capsules after each meal

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Healthy Japanese adults

Key exclusion criteria

1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction

2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases

3. Currently taking medicines and/or herbal medicines

4. Allergic to medicines or foods related to the test food of this trial

5. Pregnant, lactating, or planning to get pregnant during the trial period

6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial

7. Judged unsuitable for participating in this trial by physician

Target sample size

32


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuo YAMAMOTO

Organization

ORTHOMEDICO, Inc.

Division name

R&D Department

Zip code


Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.

TEL

03-3818-0610

Email

kazu@orthomedico.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoko SUZUKI

Organization

ORTHOMEDICO, Inc.

Division name

R&D Department

Zip code


Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.

TEL

03-3818-0610

Homepage URL


Email

nao@orthomedico.jp


Sponsor or person

Institute

ORTHOMEDICO, Inc.

Institute

Department

Personal name



Funding Source

Organization

Temahimado Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

1. Seishin-kai Medical Association Inc, Takara Medical Clinic.

2. Evaluation Center of Health and Nutrition Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団 盛心会 タカラクリニック (東京都)
Seishin-kai Medical Association Inc, Takara Medical Clinic (Tokyo)


Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 19 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Suzuki N, Yamamoto K, Kakino K, Takara T. Safety Evaluation of the Safety of Excessive Ingestion of Garlic-egg Yolk-containing Supplements in Humans-An Open-label Trial-. Jpn Pharmacol Ther. 2016; 44(12): 1795-1819.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 13 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 14 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 08 Month 18 Day

Last modified on

2017 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027262


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name